Drugs / Ribostat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06100939 | Oct 2023 → May 2026 | keratoconus | Epion Therapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ribostat | “Drug: Ribostat riboflavin and sodium iodide ophthalmic solution” NCT06100939 ↗ |